InsiderTrades.com logo
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.
Karen Noblett net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Karen Noblett Biography and Net Worth

Insider of Axonics
Dr. Noblett is Board Certified in OB/GYN and in Female Pelvic Medicine and Reconstructive Surgery. Before joining Axonics, she had a long career in academic medicine. She served as the founding Chair and Professor of the Department of OB/GYN in the School of Medicine at the University of California, Riverside, from 2014-2017. Before that, she was a professor in the OB/GYN Department and Fellowship and Division Director for Urogynecology at the University of California, Irvine, as well as the Interim Chief Medical officer.

Dr. Noblett completed her Master of Advanced Studies in Clinical Research at the University of California, San Diego. She has published over 50 peer-reviewed journal articles and authored multiple book chapters. She is a recognized expert in the field of Sacral Neuromodulation.

What is Karen Noblett's net worth?

The estimated net worth of Karen Noblett is at least $2.44 million as of January 31st, 2024. Dr. Noblett owns 34,428 shares of Axonics stock worth more than $2,443,699 as of November 21st. This net worth approximation does not reflect any other assets that Dr. Noblett may own. Additionally, Dr. Noblett receives a salary of $651,400.00 as Insider at Axonics. Learn More about Karen Noblett's net worth.

How old is Karen Noblett?

Dr. Noblett is currently 61 years old. There are 7 older executives and no younger executives at Axonics. The oldest executive at Axonics is Mr. Raymond W. Cohen, Co-Founder, Chief Executive Officer and Director, who is 65 years old. Learn More on Karen Noblett's age.

What is Karen Noblett's salary?

As the Insider of Axonics, Inc., Dr. Noblett earns $651,400.00 per year. There are 5 executives that earn more than Dr. Noblett. The highest earning executive at Axonics is Mr. Raymond W. Cohen, Co-Founder, Chief Executive Officer and Director, who commands a salary of $1,750,000.00 per year. Learn More on Karen Noblett's salary.

How do I contact Karen Noblett?

The corporate mailing address for Dr. Noblett and other Axonics executives is 26 TECHNOLOGY DRIVE, IRVINE CA, 92618. Axonics can also be reached via phone at (949) 396-6322 and via email at [email protected]. Learn More on Karen Noblett's contact information.

Has Karen Noblett been buying or selling shares of Axonics?

Karen Noblett has not been actively trading shares of Axonics in the last ninety days. Most recently, Karen Noblett sold 11,288 shares of the business's stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $67.74, for a transaction totalling $764,649.12. Following the completion of the sale, the insider now directly owns 34,428 shares of the company's stock, valued at $2,332,152.72. Learn More on Karen Noblett's trading history.

Who are Axonics' active insiders?

Axonics' insider roster includes Juliet Bakker (Director), Raymond Cohen (Co-Founder, Chief Executive Officer and Director), Danny Dearen (Insider), Alfred Ford, Jr. (Insider), Kari Keese (CFO), Jane Kiernan (Director), Esteban Lopez (Director), Robert Mcnamara (Director), Karen Noblett (Insider), Rinda Sama (COO), and John Woock (CMO). Learn More on Axonics' active insiders.

Are insiders buying or selling shares of Axonics?

During the last year, insiders at the sold shares 8 times. They sold a total of 92,797 shares worth more than $6,275,226.67. The most recent insider tranaction occured on October, 2nd when CFO Kari Leigh Keese sold 2,961 shares worth more than $205,523.01. Insiders at Axonics own 1.9% of the company. Learn More about insider trades at Axonics.

Information on this page was last updated on 10/2/2024.

Karen Noblett Insider Trading History at Axonics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/31/2024Sell11,288$67.74$764,649.1234,428View SEC Filing Icon  
1/8/2024Sell15,999$69.00$1,103,931.0018,216View SEC Filing Icon  
12/28/2023Sell7,051$63.28$446,187.2834,215View SEC Filing Icon  
12/26/2023Sell949$63.00$59,787.0041,266View SEC Filing Icon  
9/7/2022Sell10,454$71.53$747,774.6231,599View SEC Filing Icon  
3/18/2022Sell13,531$57.23$774,379.13View SEC Filing Icon  
2/3/2022Sell6,682$48.25$322,406.50View SEC Filing Icon  
See Full Table

Karen Noblett Buying and Selling Activity at Axonics

This chart shows Karen Noblett's buying and selling at Axonics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Axonics Company Overview

Axonics logo
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Read More

Today's Range

Now: $70.98
Low: $70.98
High: $70.98

50 Day Range

MA: $70.00
Low: $68.70
High: $70.98

2 Week Range

Now: $70.98
Low: $55.09
High: $71.05

Volume

N/A

Average Volume

571,295 shs

Market Capitalization

$3.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.